Network meta-analysis of mineralocorticoid receptor antagonists for diabetic kidney disease
Diabetic kidney disease (DKD) is one of the major causes of end-stage renal disease (ESRD). To evaluate the efficacy and safety of different types of mineralocorticoid receptor antagonists (MRAs) in diabetic kidney disease patients, we conducted this network meta-analysis by performing a systematic...
Saved in:
Main Authors: | Yichuan Wu (Author), Huanjia Lin (Author), Yuan Tao (Author), Ying Xu (Author), Jiaqi Chen (Author), Yijie Jia (Author), Zongji Zheng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tubular epithelial cell-derived extracellular vesicles induce macrophage glycolysis by stabilizing HIF-1α in diabetic kidney disease
by: Yijie Jia, et al.
Published: (2022) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Daiji Kawanami, et al.
Published: (2021) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021) -
Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease
by: Mai Rosenberg, et al.
Published: (2024) -
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
by: Funder JW
Published: (2013)